Sponsors (2)
The resolution would boost awareness, diagnosis, and research—especially benefitting veterans and people with dystonia—at the cost of additional federal spending and a risk that resources may be concentrated within military and veteran health systems rather than civilian care.
People with dystonia (patients and those with chronic movement disorders) would see greater awareness, earlier diagnosis, and expanded treatment options—potentially improving daily functioning and quality of life.
Veterans and servicemembers would get more targeted diagnosis, care, and access to treatments through expanded DoD and VA research and clinical activities.
Patients with dystonia could benefit from increased research funding and activity that may accelerate development of better therapies (e.g., optimized deep brain stimulation, medications, and supportive therapies).
Taxpayers may face additional federal spending to expand DoD/VA research and treatment programs, which could increase budgetary pressure or require funds to be reallocated from other priorities.
Patients in civilian healthcare settings and civilian hospitals could receive less attention or resources if emphasis and funding are concentrated on military and veteran causes of dystonia.
Based on analysis of 2 sections of legislative text.
Introduced September 17, 2025 by James E. Banks · Last progress September 17, 2025
Recognizes dystonia as a neurological movement disorder that affects an estimated 250,000–300,000 people in the U.S. and calls for greater awareness, research, and support to improve diagnosis, treatments, and care. The text notes available symptom-managing treatments, the disorder’s physical, social, emotional, and financial impacts, and highlights that servicemembers and veterans may develop dystonia related to service; it urges DoD and VA health systems to support research and treatment access.